Tutorials › Optimal Design and Model-Informed Dosing › Physiologic and Exposure Plausibility Checks

Clinical Utility and Safety Nets · Tutorial 486 of 497

Physiologic and Exposure Plausibility Checks

You will learn to apply layered physiologic and exposure checks, investigate discrepancies, and avoid treating unusual patients as erroneous data.

Advanced 10 min read

What You'll Learn

  • Distinguish impossible values from values that are merely unusual for a patient.
  • Check whether concentrations agree with dose history, sampling time, units, and a stated pharmacokinetic model.
  • Use serial concentrations to assess whether an exposure pattern is internally consistent.
  • Investigate discrepancies without silently changing or discarding patient data.
  • Recognize the assumptions and limitations of physiologic and exposure plausibility checks.

Why Plausibility Checks Matter

A dosing system can receive inputs in the wrong units, use a concentration collected at an unexpected time, or calculate an output that conflicts with basic physiology. Those problems can arise even when the data pass ordinary format checks. Conversely, a value far from what is typical may be correct for a particular patient. The central task is therefore not simply to label values “normal” or “abnormal,” but to decide what should be verified before the value is used.

Physiologic and exposure plausibility checks examine whether an input or predicted result is compatible with physical constraints, relevant patient characteristics, dose history, and the model’s assumptions. They complement input validation and out-of-domain assessment: a value can be correctly formatted and still be implausible, while a patient can be unusual without the record being wrong. A plausibility flag is a prompt to investigate, not proof of a data error or a clinical conclusion.

Definition: A physiologic plausibility check asks whether a patient input is physically possible or credible in its clinical and demographic context. An exposure plausibility check asks whether a measured or predicted drug concentration is consistent with dose, timing, units, patient-specific disposition, and the assumptions of the pharmacokinetic model.

The strength of a check should match the kind of constraint. A negative body weight is physically impossible and can be rejected as an input. An adult record with a very low weight may be inconsistent with the record’s age or height, but might instead reflect a special circumstance or a data-linkage problem. A high laboratory value may be unusual yet genuine. Treating all three situations as equivalent would make the check unreliable.

Build Checks Around Explicit Assumptions

Before interpreting a discrepancy, state what the check assumes. For a physiologic check, this includes the variable’s units, the patient group to which the expected range applies, and whether the range is a physical boundary, a broad plausibility screen, or a clinical reference interval. Reference intervals describe distributions in defined populations; they are not universal limits on what an individual can experience.

For an exposure check, specify the dosing history, sampling time, route, concentration units, and pharmacokinetic model. A predicted concentration is conditional on these assumptions. If the dose time is wrong or an additional dose was given, a mismatch does not establish that the model calculation or concentration measurement is erroneous.

A useful operational distinction is between a hard constraint and a soft screen. Hard constraints include values that violate a mathematical or physical requirement, such as a negative elapsed time. A soft screen identifies a value that warrants review because it is uncommon or inconsistent with context. Soft screens should generally flag rather than overwrite a record. An action threshold should be defined for the intended setting and supported by relevant measurement, model, and population information—not borrowed uncritically from a general reference range.

Worked Example: A Weight That Conflicts With Its Record

Suppose a hypothetical dosing record describes an adult who is 1.72 m tall and lists a body weight of 7.2 kg. The system’s locally defined screen flags adult records with a body-mass index below 10 kg/m² for review. Determine whether the record passes the screen and what the flag means.

Body-mass index is calculated as weight in kilograms divided by height in metres squared:

$$ \mathrm{BMI}=\frac{7.2\ \mathrm{kg}}{(1.72\ \mathrm{m})^2} =\frac{7.2}{2.9584}\ \mathrm{kg/m^2} =2.434\ \mathrm{kg/m^2}. $$

The computed value is below the stated screening threshold of 10 kg/m², so the record should be flagged. This calculation does not show that the weight is impossible, nor does it identify the correct weight. The discrepancy could reflect a misplaced decimal, a unit or transcription problem, a mismatched patient record, or an exceptional clinical context. The appropriate response is to verify the source and context before using the value in a dosing calculation. The screen must not silently replace 7.2 kg with a more typical number.

Check Exposure Against Dose and Time

A concentration-time model gives a structured way to assess whether exposure is internally consistent. For illustration, consider a one-compartment model after an intravenous bolus. Assume instantaneous mixing, linear elimination, constant clearance and volume over the interval, and no additional doses. If the administered dose is \(D\), the apparent volume of distribution is \(V\), clearance is \(CL\), and time since the bolus is \(t\), then the concentration is

$$ C(t)=\frac{D}{V}\exp\left(-\frac{CL}{V}t\right). $$

This simple model is not appropriate for every drug or regimen. Its value here is that the conditions are explicit: an infusion, absorption phase, another dose, or changing clearance would require a different prediction. Even when this model is a reasonable approximation, a predicted concentration is not an exact boundary. Parameter uncertainty, assay error, and model misspecification all contribute to differences between observed and predicted values.

A short derivation gives a useful serial check. Define \(k=CL/V\). For two times \(t_1\) and \(t_2\) after the same bolus, under the stated model,

$$ \frac{C(t_2)}{C(t_1)} = \frac{(D/V)\exp(-kt_2)}{(D/V)\exp(-kt_1)} = \exp[-k(t_2-t_1)]. $$

The dose and volume terms cancel. When \(CL>0\) and \(t_2>t_1\), this ratio is below 1, so concentrations decline over time under these assumptions. A concentration increase may indicate a timing or dose-history problem, a unit mismatch, or that the assumptions do not fit the patient and regimen. It does not, by itself, tell which explanation is correct.

Worked Example: Converting a Concentration Before Flagging It

In a hypothetical case, a patient receives a 400 mg intravenous bolus. For an illustrative one-compartment prediction, use \(V=40\) L and \(CL=4\) L/h. A sample is collected 6 h after the bolus and the laboratory reports 5,500 µg/L. Check the predicted concentration and compare it with the measurement.

The model assumptions are those just stated: bolus administration, linear elimination, constant \(V\) and \(CL\), and no intervening dose. First, \(CL/V=4/40=0.1000\ \mathrm{h^{-1}}\), and \(D/V=400/40=10.00\ \mathrm{mg/L}\). Thus:

$$ C(6)=10.00\exp[-(0.1000)(6)]\ \mathrm{mg/L} =10.00\exp(-0.6000)\ \mathrm{mg/L} =5.488\ \mathrm{mg/L}. $$

Convert the reported measurement using \(1\ \mathrm{mg}=1{,}000\ \mathrm{\mu g}\):

$$ 5{,}500\ \mathrm{\mu g/L} \left(\frac{1\ \mathrm{mg}}{1{,}000\ \mathrm{\mu g}}\right) =5.500\ \mathrm{mg/L}. $$

The converted measurement, 5.500 mg/L, is close to the predicted 5.488 mg/L. Their absolute difference is \(5.500-5.488=0.012\ \mathrm{mg/L}\). This agreement supports unit consistency and the stated timing in this illustrative calculation; it does not prove that the model is correct. If the system had interpreted 5,500 µg/L as 5,500 mg/L, the apparent discrepancy would be a unit-handling error of a factor of 1,000, not evidence of extraordinary exposure.

Distinguish a Data Problem From a Patient Difference

A useful investigation looks for independent evidence. First verify the identity, units, collection time, dose history, and source record. Then compare the value with other relevant patient information and, where appropriate, repeated measurements. If a verified value remains unusual, assess whether it can be explained by a patient-specific characteristic or by limitations of the assumed model. Repetition is informative, but a repeated measurement can also share a systematic error; it is not automatically definitive.

The following example illustrates why a value should not be judged only against a typical parameter value. It uses the same simple model, with an explicitly different clearance. The calculation checks whether the serial pattern is consistent with that clearance; it does not establish the patient’s clearance from concentration data alone.

Worked Example: A Credible Pattern With Lower Clearance

Consider a hypothetical patient given a 400 mg intravenous bolus. For an illustrative patient-specific model, let \(V=40\) L and \(CL=2.0\) L/h. Concentrations are measured at 6 h and 12 h as 7.41 mg/L and 5.49 mg/L, respectively. Assume no dose was given between samples and that the one-compartment assumptions are reasonable over this interval. Check both concentrations and their serial ratio.

Here, \(D/V=10.00\ \mathrm{mg/L}\) and \(CL/V=2.0/40=0.0500\ \mathrm{h^{-1}}\). The predictions are:

$$ C(6)=10.00\exp[-(0.0500)(6)]=7.408\ \mathrm{mg/L}, $$ $$ C(12)=10.00\exp[-(0.0500)(12)]=5.488\ \mathrm{mg/L}. $$

The predicted ratio from 6 h to 12 h is

$$ \frac{C(12)}{C(6)} =\exp[-(0.0500)(12-6)] =\exp(-0.3000) =0.7408. $$

The measured ratio is \(5.49/7.41=0.7409\), close to the model ratio after rounding. Both measurements also closely match their respective predictions. Under the stated assumptions, this is a coherent declining exposure pattern for the lower-clearance model. It would be inappropriate to flag the patient as erroneous solely because the concentrations exceed those predicted using a clearance of 4 L/h. The example does not show that lower clearance is clinically harmless or that the model inputs are correct; those are separate questions.

Diagnostics, Alternatives, and Limitations

When a check flags a value, record what triggered the flag and what was verified. Useful diagnostic questions include:

  • Are the units, decimal placement, patient identity, and measurement time consistent across the source record and dosing system?
  • Does the recorded dose history include the route, administration time, and any additional or delayed doses needed to interpret the sample?
  • Does the discrepancy persist after unit conversion and use of the correct sampling time?
  • Is the patient-specific model applicable over the interval, or could a change in physiology or regimen invalidate its assumptions?
  • Do other measurements or records support a data problem, or do they support a genuine unusual patient value?

Plausibility checks are not substitutes for other safety methods. A hard bound is transparent and appropriate for a true impossibility, but it cannot distinguish two plausible values. A broad population reference range is easy to implement, but may flag many genuine unusual patients and miss errors that remain inside the range. A model-based exposure check can use dose and timing information, but inherits the model’s assumptions and uncertainty. Clinical review can integrate context, but may be inconsistent if the question and response are not specified. These approaches are complementary; no single screen can establish that a patient or record is correct.

A common failure is to treat a soft threshold as a rule that automatically deletes, caps, or “corrects” a value. For example, a concentration above a typical range may be caused by a wrong unit, but it may also reflect a correct sample in a patient with different disposition. The correction is to flag the discrepancy, check its provenance and assumptions, and retain the distinction between unverified, confirmed data error, and verified unusual value. A plausibility check should also be evaluated for false alarms and missed discrepancies in the setting where it will be used. Thresholds that are too narrow can create alarm fatigue; thresholds that are too broad can fail to catch consequential errors.

Finally, plausibility is not the same as suitability for a dosing decision. These checks assess whether information appears credible enough to interpret under stated assumptions. They do not establish that a recommended dose is appropriate for every clinical circumstance. Keep that scope clear when recording a flag or designing the system’s response.

Key takeaway: State the assumptions behind each physiologic or exposure check. Use hard constraints for genuine impossibilities and soft flags for unusual or inconsistent values. Verify discrepancies; do not automatically convert “unusual” into “wrong.”

Check Your Understanding

Answer each question, then compare your reasoning with the solutions below.

  1. A concentration is reported in µg/L, but the dosing system expects mg/L. What must be checked before comparing the measurement with a prediction?
  2. Under the one-compartment bolus model, what happens to concentration between two increasing post-dose times when \(CL>0\)? State the assumptions that support the conclusion.
  3. A physiologic soft screen flags a value that is confirmed in the source record and supported by repeated measurements. Does that establish a data error?
  4. For a bolus dose, suppose \(V=20\) L and \(CL=2\) L/h. What fraction of the concentration at 4 h is predicted to remain at 8 h under the model?

Solutions. (1) Verify the units and convert before comparison: \(1\ \mathrm{mg}=1{,}000\ \mathrm{\mu g}\), so a value in µg/L must be divided by 1,000 to express it in mg/L. Also verify sampling time and dose history because the prediction depends on them. (2) It decreases, since \(C(t_2)/C(t_1)=\exp[-(CL/V)(t_2-t_1)]<1\) when \(V>0\), \(CL>0\), and \(t_2>t_1\). This result assumes the stated bolus, one-compartment, linear-elimination model with constant parameters and no intervening dose. (3) No. Confirmation makes a genuine unusual value more credible, though the record and measurement process still need appropriate review. A soft flag is not proof of error. (4) \(CL/V=2/20=0.1000\ \mathrm{h^{-1}}\), so the fraction is \(\exp[-0.1000(8-4)]=\exp(-0.4000)=0.6703\). Under the model, about 67.03% of the concentration at 4 h remains at 8 h.

Clinical Biostats